$Adial Pharmaceuticals (ADIL.US)$ thats why it not moving it...
thats why it not moving it will go sky rocket According to TipRanks.com, McCarthy is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -13.9% and a 31.9% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Genenta Science SpA Sponsored ADR, Lipella Pharmaceuticals, Inc., and SELLAS Life Sciences Group.
Currently, the analyst consensus on Adial Pharmaceuticals is a Moderate Buy with an average price target of $26.00.
Currently, the analyst consensus on Adial Pharmaceuticals is a Moderate Buy with an average price target of $26.00.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
71306807 : how often are the " price targets " achieved ?